Bloom Burton & Co. Inc. Announces Exercise of Satellos Bioscience Inc. Warrants
Toronto, Ontario--(Newsfile Corp. - May 20, 2025) - Bloom Burton & Co. Inc. (Bloom Burton) announces that, today, it exercised 3,200,000 common share purchase warrants (Warrants) of Satellos Bioscience Inc. (Corporation) at $0.50 per share for aggregate consideration of $1,600,000, and the remaining 3,360,474 unexercised Warrants expired. This resulted in a decrease of beneficial holdings to under 10%, requiring the filing of an early warning report in connection therewith. Prior to this acquisition, Bloom Burton, its affiliates and Brian...
2025-05-20 7:01 PM EDT
Three Finalists Announced for the 2025 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - May 14, 2025) - Bloom Burton & Co. is pleased to announce the finalists for the 2025 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The finalists for 2025, in alphabetical order, are: Mark Nawacki, former President and Chief Executive Officer, Searchlight PharmaOliver Technow, former Chief Executive Officer, BIOVECTRA Ali Tehrani,...
2025-05-14 7:00 AM EDT
Orpyx Medical Technologies Inc. to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
Calgary, Alberta--(Newsfile Corp. - May 2, 2025) - Orpyx® Medical Technologies Inc. ("Orpyx"), a leader in digital health solutions for the prevention of diabetic foot complications, today announced that Justine Jones, Senior Vice President, Commercial, will present at the 2025 Bloom Burton & Co. Healthcare Investor Conference held at the Metro Toronto Convention Centre.Ms. Jones will deliver an overview of Orpyx's innovative technologies and commercial strategy on Tuesday, May 6, 2025, at 3:30 PM ET in Room 104B.The Bloom Burton...
2025-05-02 10:08 AM EDT
Entos Pharmaceuticals (Entos) Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference
Edmonton, Alberta--(Newsfile Corp. - May 1, 2025) - Entos Pharmaceuticals (Entos), a clinical-stage genetic medicines company headquartered in Edmonton, Canada, with offices in London, UK, and San Diego, USA, will be participating in the 2025 Bloom Burton & Co. Healthcare Investor Conference, which will take place on May 5 and 6 at the Metro Toronto Convention Centre.Dates: Monday May 5, 2025 - Tuesday May 6, 2025
2025-05-01 8:30 AM EDT
Altis Labs, Inc. Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 30, 2025) - Altis Labs, Inc., the computational imaging company accelerating clinical trials with AI, will be participating in the 2025 Bloom Burton & Co. Healthcare Investor Conference, which will take place on May 5 and 6 at the Metro Toronto Convention Centre.Dates:Monday May 5, 2025 - Tuesday May 6, 2025 Time:
2025-04-30 9:00 AM EDT
Conavi Medical to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 25, 2025) - Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) ("Conavi" or the "Company"), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that Thomas Looby, CEO of Conavi Medical, will present and participate in one-on-one meetings at the 2025 Bloom Burton & Co. Healthcare Investor Conference being held in Toronto on May 5-6, 2025.Details on the presentation are as follows:Date:...
2025-04-25 7:00 AM EDT
Specialty Medical Partners Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 15, 2025) - Specialty Medical Partners, We aim to establish Canada’s most comprehensive outpatient specialty medical group, integrating all aspects of non-hospital-based specialty care., will be participating in the 2025 Bloom Burton & Co. Healthcare Investor Conference, which will take place on May 5 and 6 at the Metro Toronto Convention Centre.Dates: Monday May 5, 2025 - Tuesday May 6, 2025Time:
2025-04-15 9:22 AM EDT
PharmaCorp Rx Inc. Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 14, 2025) - PharmaCorp Rx Inc. (TSXV: PCRX) will be participating in the 2025 Bloom Burton & Co. Healthcare Investor Conference, which will take place on May 5 and 6 at the Metro Toronto Convention Centre.Dates:Monday May 5, 2025 - Tuesday May 6, 2025 Time:8:30 AM - 5:00 PM ET
2025-04-14 7:30 AM EDT
Bloom Burton & Co. Announces the 2025 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - January 29, 2025) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce the launch of the 2025 Bloom Burton Award and to open nomination submissions from the public at large on or before March 31, 2025. The finalists for the 2025 Bloom Burton Award will be announced at the 2025 Bloom Burton & Co. Healthcare Investor Conference, taking place at the Metro Toronto Convention Centre from May 5-6, 2025.
2025-01-29 7:00 AM EST
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton) announces that, today, it acquired 1,692,250 common shares (Shares) of Satellos Bioscience Inc. (Corporation) in connection with a public offering of the Corporation by way of a prospectus supplement dated December 17, 2024 to the short form prospectus dated April 7, 2024. Bloom Burton purchased the Shares at a price of $0.90 per Share for total consideration of $1,523,025. Combined with former treasury issuances...
2024-12-20 5:03 PM EST
Roberto Bellini Receives the 2024 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - September 27, 2024) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Roberto Bellini, former President and Chief Executive Officer of BELLUS Health, as the recipient of the 2024 Bloom Burton Award. 2024 Bloom Burton Award Winner Roberto Bellini, former President and Chief Executive Officer of BELLUS Health
2024-09-27 7:00 AM EDT
Three Finalists Announced for the 2024 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - April 19, 2024) - Bloom Burton & Co. is pleased to announce the finalists for the 2024 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The finalists for 2024, in alphabetical order, are: Roberto Bellini, former President and Chief Executive Officer, Bellus HealthTom Frohlich, former Chief Operating Officer, Chinook TherapeuticsFrançois Ravenelle,...
2024-04-19 8:11 AM EDT
AlayaCare to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 16, 2024) - AlayaCare, a leading home-based care technology platform, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. Dates:Tuesday April 16, 2024-Wednesday April 17, 2024
2024-04-16 10:00 AM EDT
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. Dates:Tuesday April 16, 2024-We
2024-04-15 5:00 AM EDT
Orpyx to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 12, 2024) - Orpyx, a med tech + touch company dedicated to transforming diabetic limb management, is pleased to announce that Dr. Breanne Everett, Founder and CEO, will be presenting at the 2024 Bloom Burton & Co. Healthcare Investor Conference on April 16th in Toronto. Attendees will have the opportunity to gain insights into Orpyx’s strategic initiatives and plans for continued success., will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference,...
2024-04-12 5:00 PM EDT
Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Beverly, Massachusetts--(Newsfile Corp. - April 10, 2024) - Hamilton Thorne Ltd. (TSX: HTL) (OTC Pink: HTLZF), Hamilton Thorne Ltd. a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets., will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. Dates:
2024-04-10 9:00 AM EDT
Xediton Pharmaceuticals Inc. To Present at The 2024 Bloom Burton & Co. Healthcare Investor Conference
Oakville, Ontario--(Newsfile Corp. - April 9, 2024) - Xediton Pharmaceuticals Inc., a leading Canadian specialty pharmaceutical company, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. Dates:Tuesday April 16, 2024-Wednesday April 17, 2024
2024-04-09 3:52 PM EDT
Entos Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Edmonton, Alberta--(Newsfile Corp. - April 9, 2024) - Entos Pharmaceuticals, (Entos), a genetic medicines company pioneering the development of life-changing medicines to patients with its Fusogenix PLV nucleic acid delivery technology, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. Dates:Tuesday April 16, 2024-Wednesd
2024-04-09 2:15 PM EDT
SRx Health Solutions Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 9, 2024) - SRx Health Solutions Inc., a leading Canadian healthcare service provider specializing in the Specialty Pharmacy segment of the pharmaceutical industry, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. Dates:Tuesday April 16, 2024-Wednesday April 17, 2024
2024-04-09 11:15 AM EDT
CareRx to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference on Wednesday, April 17, 2024
Toronto, Ontario--(Newsfile Corp. - April 4, 2024) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that Puneet Khanna, President and Chief Executive Officer, will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference, taking place on April 16-17, 2024 at the Metro Toronto Convention Centre, North Building, 255 Front Street West, Toronto. Mr. Khanna's presentation is scheduled for Wednesday, April 17,...
2024-04-04 4:17 PM EDT